Introduction to the Life-course Immunization in Vietnam (LCI) Report
Vietnam’s healthcare system faces an increasing burden from preventable diseases, especially among its aging population. The key to mitigating this is life-course immunization - providing vaccinations throughout all stages of life. This approach is crucial to Vietnam's journey toward achieving universal healthcare, reducing the spread of preventable diseases, and safeguarding the country's economic resilience. With strategic partnerships between the public and private sectors, Vietnam stands to benefit both in terms of public health and as a preferred destination for healthcare investments.
Through the adoption of adult vaccination programs, Vietnam can work together to significantly reduce the economic and social burden of disease, fostering a stronger and more resilient society.
Luke Treloar
Partner
Head of Strategy Group
Head of Infrastructure, Government & Healthcare
KPMG in Vietnam
Life-course Immunization in Vietnam
Opportunities to meaningfully advance preventable disease defense
Download English PDF (5.1 MB) ⤓
Download Vietnamese PDF (2.7 MB) ⤓
Key takeaways
Vietnam's healthcare system is under pressure due to a rapidly aging population and an evolving disease landscape.
Vietnam’s golden structure of nearly 70% of the population falling within the working-age range is entering an ageing trend, characterized by a decrease in the pregnant demographic of 1.2% from 2022 – 2030 and an increase in the elderly of 4.4% in the same period. This highlights a shift towards a larger and more vulnerable elderly population with fewer working adults to support them, the demand for healthcare services is likely to grow.
The Vietnamese government is committed to expanding immunization coverage, ensuring equitable access to life-saving vaccines.
The Vietnamese government has demonstrated commitment to expanding immunization coverage through several key policies from 2021 to 2024. These include the introduction of roadmap to increase the variety of vaccines funded under the EPI such as Rotavirus, pneumococcal, and seasonal flu by 2030. Additionally, Decree No. 104/2016/ND-CP centralized vaccine procurement, ensuring a consistent supply and sustainable funding for broader immunization coverage.
Opportunities for Vietnam
Life-course immunization is not only a public health strategy but a critical economic one. As Vietnam transitions from a communicable disease-focused healthcare system to one addressing non-communicable diseases, life-course immunization will play a pivotal role in reducing the healthcare burden. Collaborative efforts between the public and private sectors will maximize impact, offering widespread benefits such as reduced public health costs, increased investment in healthcare infrastructure, and improved patient outcomes.
The Way Forward
To strengthen life-course immunization, Vietnam must address existing barriers, including limited awareness, accessibility issues in rural areas, and the high cost of vaccines. Policy reforms, enhanced public-private collaboration, and increased awareness are key steps toward achieving a robust life-course immunization strategy. By learning from international best practices and focusing on innovation, Vietnam can create a sustainable and resilient healthcare system.
KPMG's Collaborative Research: Addressing healthcare challenges and importance of LCI in Vietnam
In recognition of the existing challenges and potential opportunities, KPMG, Sanofi-Aventis, and the Vietnam Association of Preventive Medicine have partnered to conduct a comprehensive research study on life-course immunization programs in Vietnam. This research draws upon benchmarking against comparable markets and insights from extensive surveys of industry experts. The resulting report highlights the significant benefits that life-course immunization programs can offer to Vietnam and provides a detailed roadmap for successful implementation.
